venezuelan equine encephalitis

GeneSegues gets gov’t contract to develop a topical vaccine for Venezuelan encephalitis

Minneapolis vaccine developer GeneSegues Therapeutics has a new government contract to develop a DNA vaccine against Venezuelan equine encephalitis virus – an infectious disease that has the potential to be used as a bioweapon, the feds say. It just received a $550,000 contract from the U.S. Defense Threat Reduction Agency to work with the U.S. Army Medical […]

By Meghana Keshavan

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab

Partnership Post

When Investment Rhymes with Canada

Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.

By Julien Rosan and Tina Kotrych - Global Affairs Canada